Nasdaq

HCW Biologics CEO Hing C. Wong to Participate in Panel Discussion at 2025 GenScript Biotech Global Forum

Dr. Hing C. Wong, the Founder and CEO of HCW Biologics, is participating as a panelist at the prestigious 2025 GenScript Biotech Global Forum, highlighting the company's expertise and commitment to ...
Nasdaq

Genscript Biotech Announces CEO Resignation and Leadership Changes

Genscript Biotech Corporation has announced the resignation of Dr. Liu Zhenyu from his role as rotating chief executive officer, effective 31 December 2024, as he pursues personal career development.
Seeking Alpha

The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development

LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech ...
Seeking Alpha

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...